Market Research Future has added a report titled “RSV Diagnostics Market Research Report – Forecast to 2023” to its offering. The report provides an in-depth analysis of regional data and an accurate projection of the market size and share of the Top 10 market players across the globe.
Respiratory Syncytial Virus (RSV) is a virus that can cause serious respiratory infections such as pneumonia and bronchitis. The increasing incidence rate of respiratory infections, growing demand for in-vitro diagnostics, and growing neonatal population are major factors propelling the growth of the market. For instance, according to the Centres for Disease Control and Prevention, in the United States, RSV on an average lead to 57,527 hospitalizations among children below five years of age. On the other hand, some factor such as lack of availability of specific treatment options for RSV infections and the high number of other pathogens that cause similar symptoms of respiratory illness may hamper the growth of the market during the assessment period.
Get Premium Sample Copy @ https://www.marketresearchfuture.com/sample_request/6217
Global RSV Diagnostics Key Players:
Some of the key players in the global RSV diagnostics market are Quest Diagnostics, Biomerieux, Becton, Dickinson, and Company (BD), Abbott, F. Hoffman-La Roche Ltd., Danaher Corporation, Thermo Fisher Scientific, Biocartis, Luminex, Hologic, Fast Track Diagnostics, Bio-Rad Laboratories Inc., Alere, Inc., Quidel Corporation, and others.
The global RSV diagnostics market is segmented on the basis of the product, method, and end-user. On the basis of the product, the market is classified into kits and assays, instruments, and other products. The global RSV diagnostics market on the basis of the method is segmented into molecular diagnostics, rapid antigen detection test, gel microdroplets, flow cytometry, and others. The rapid antigen detection tests are further classified into enzyme-linked immunosorbent assays, immunofluorescence assays, and other rapid antigen detection tests. Further, the other rapid antigen detection tests are classified into chromatographic immunoassays and optical immunoassays. Furthermore, on the basis of end-user, the market is segmented into hospitals and clinics, clinical laboratories, home care, and others.
The Americas is likely to dominate the global RSV diagnostics market during the forecast period. The market growth is attributed to increasing incidences of RSV infections, increasing government funding’s, and increasing infant population. Additionally, growing demand for molecular diagnostics and chromatographic immunoassays in this region owing to the high accuracy, sensitivity, and specificity these devices provide. For instance, as per the data stated by the Centres for Disease Control and Prevention, in the United States, RSV leads to an estimated 2.1 million outpatient visits among children below five years of age every year. Europe is anticipated to be the second largest market in the global RSV diagnostics market. The European market is expected to grow during the forecast period owing to the growing occurrence of RSV infections and growing government funding for respiratory diseases. Asia Pacific is expected to be the fastest growing market owing to the high population base, increasing prevalence of respiratory diseases such as pneumonia and bronchitis, and growing demand for automated healthcare testing for the accurate diagnosis of diseases. Furthermore, the Middle East and Africa are expected to show the least growth in the global RSV diagnostics market. The market growth in these regions is attributed to the constantly improving healthcare infrastructure, economic development, and rising patient awareness levels.
Table of Contents:
Chapter 1. Report Prologue
Chapter 2. Market Introduction
Chapter 3. Research Methodology
Chapter 4. Market Dynamics
Chapter 5. Market Factor Analysis
Chapter 6. Global RSV Diagnostics Market, By Product
Chapter 7. Global RSV Diagnostics Market, By Method
Chapter 8. Global RSV Diagnostics Market, By End-User
Chapter 9. Global RSV Diagnostics Market, By Region
Chapter 10. Company Landscape
Chapter 11. Company Profiles
Chapter 12 MRFR Conclusion
Chapter 13 Appendix
List of Tables
Table 1 Global RSV Diagnostics Market Synopsis, 2018–2023
Table 2 Global RSV Diagnostics Market Estimates And Forecast, 2018–2023, (USD Million)
Table 3 Global RSV Diagnostics Market, By Region, 2018–2023, (USD Million)
Table 4 Global RSV Diagnostics Market, By Product, 2018–2023, (USD Million)
Table 5 Global RSV Diagnostics Market, By Method, 2018–2023, (USD Million)
Table 6 Global RSV Diagnostics Market, By End-User, 2018–2023, (USD Million)
Browse Full Reports @ https://www.marketresearchfuture.com/reports/rsv-diagnostics-market-6217
List of Figures
Figure 1 Research Process
Figure 2 Segmentation For Global RSV Diagnostics Market
Figure 3 Segmentation Market Dynamics For Global RSV Diagnostics Market
Figure 4 Global RSV Diagnostics Market Share, By Product, 2017
Figure 5 Global RSV Diagnostics Market Share, By Method, 2017
Figure 6 Global RSV Diagnostics Market Share, By End-User, 2017
Market Research Future
Office No. 528, Amanora Chambers
Magarpatta Road, Hadapsar,
Pune – 411028
Phone: +1 646 845 9312